CNS vs FHI
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 10, 2026
CNS
FHI
Investment Advisor Scores
FHI
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CNS | FHI | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 18.1159 | 10.661 | FHI |
| PEG Ratio | 1.3225 | 1.5021 | CNS |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 11.1% | 8.1% | CNS |
| Earnings Growth | 0.0% | 11.9% | FHI |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 34.6/100 | 31.6/100 | CNS |
| Profit Margin | 28.2% | 21.3% | CNS |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | EXTENDED | FHI |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CNS
DistributionPrice near a flattening SMA50 (slope -5.6%) with fading momentum, RSI 50
FHI
NeutralMixed signals - no dominant trend phase, RSI 67
Fundamentals Snapshot
| Metric | CNS | FHI |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 19.6 | 10.8 |
| Trailing P/E | 22.7 | 11.7 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.1% |
| Gross Margin | 0.5% | 0.7% |
| Operating Margin | 0.3% | 0.3% |
| EPS | 3.25 | 5.58 |
| Dividend Yield | 0.04% | 0.02% |